학술논문

Dihydropyrimidine dehydrogenase level and the redox status in patients with colorectal cancer are prognostic for adverse effects of fluoropyrimidines
Document Type
Article
Source
In: Biotechnology and Biotechnological Equipment. (Biotechnology and Biotechnological Equipment, 2021, 35(1):1247-1255)
Subject
Language
English
ISSN
13102818